This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Orwig DL et al. (2006) Hip fracture and its consequences: differences between men and women. Orthop Clin North Am 37: 611–622
Johnell O et al. (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194
Cummings SR et al. (2006) BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21: 1550–1556
Qaseem A et al. (2008) Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148: 680–684
Liu H et al. (2008) Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med 148: 685–701
Shekelle P et al. (2007) Screening men for osteoporosis: who & how. Prepared by the Greater Los Angeles Veterans Affairs Healthcare System/southern California/RAND Evidence-based Practice Center. Washington, DC: US Department of Veterans Affairs
National Osteoporosis Foundation (2008) Clinician's guide to prevention and treatment of osteoporosis. [http://www.nof.org/professionals/Clinicians_Guide.htm] (accessed 1 July 2008)
Baim S et al. (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11: 6–217.
Schousboe JT et al. (2007) Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298: 629–37
Lynn HS et al. (2008) An evaluation of osteoporosis screening tools for the osteoporotic fractures in men (MrOS) study. Osteoporos Int 19: 1087–1092
WHO Fracture Risk Assessment Tool (FRAX™) [http://www.shef.ac.uk/FRAX/index.htm]
Dawson-Hughes B et al. (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19: 449–458
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
MC Hochberg has been a consultant for Amgen, Merck, Novartis, Roche and Wyeth. RA Adler has been has been a consultant for Eli Lilly, Merck and Novartis, received speakers' fees from Merck, Novartis and Proctor & Gamble, and received grant/research support from Eli Lilly, GlaxoSmithKline, Novartis and Proctor & Gamble.
Rights and permissions
About this article
Cite this article
Hochberg, M., Adler, R. Screening for osteoporosis in men: comment on the American College of Physicians clinical guidelines. Nat Rev Rheumatol 4, 626–627 (2008). https://doi.org/10.1038/ncprheum0923
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0923
This article is cited by
-
Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX™
Osteoporosis International (2010)